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To examine the outcomes of inpatient rehabilitation for Guillain Barre Syndrome (GBS) survivors using 
the Australian Rehabilitation Outcomes Centre (AROC) database. De-identified data from the AROC 
database was analysed for all rehabilitation admissions during 2003 - 2008, using 4 classes for 
functional level. The outcomes included: Functional Independence Measure (FIM) scores and FIM 
efficiency, hospital length of stay (LOS) and discharge destination. Of 577 case episodes 58% were 
male, mean age 56.7 years, 91% were discharged to the community and 64.8% (n = 374) were in the 
lowest functional classes (217, 218 and 219). The majority of GBS survivors were treated in the public 
hospital system (434 versus 143), and had a slightly longer LOS compared with patients treated in 
private facilities (30 versus 24 days, p 0.004). The FIM for all classes (216 - 219) showed significant 
functional improvement during the admission (p < 0.000). As expected those in the most functionally 
impaired classes showed most change (FIM change: 10 in class 216, 37 in class 219). FIM efficiency was 
highest in classes 217 and 218. The year -to -year trend was towards reducing hospital LOS however 
this was not significant (p = 0.721). The AROC dataset is a valuable research tool for describing 
rehabilitation outcomes. However more specific information needs to be collected alongside the core 
AROC data to allow more meaningful evaluation of outcomes for GBS rehabilitation.  
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Guillain Barre syndrome (GBS) is an acute demyelinating 
polyneuropathy due to immune based inflammation of 
peripheral nerves and nerve roots, and presents as an 
evolving sensorimotor ascending paralysis and often 
central dysautonomia (Zochodne, 1994; Ropper et al., 
1991; Asbury and Cornblath, 1990). It affects 1 - 2 per 
100,000 persons worldwide with no geographical 
clustering (Hahn, 1998; Hughes and Rees, 1997). GBS 
affects both sexes (more male prevalence), is common in 
ages between 30 and 50 years and is a significant cause 
of disability (Khan and Ng, 2009; Khan, 2004). Although 
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survivors ambulatory (without assistive devices) within 6 
months of symptom onset, up to 15% may have residual 
neurological deficits (Meythaler, 1997). Forsberg et al. 
(2005) report ongoing impact of GBS at 2 years after 
onset on the individual’s activities of daily living, work and 
social activity and quality of life (QoL). The impact of GBS 
on the families, health services and resource utilization, 
and overall financial costs are unknown (Khan and Ng, 
2009; Meythaler, 1997). 
There is now a substantial body of evidence to support 
effectiveness of rehabilitation following neurological 
conditions such as stroke (Langhorne et al., 2001), 
acquired brain injury (Turner et al., 2005) and Multiple 
sclerosis (MS) (Khan et al., 2008; Khan et al., 2007), and 
the place for rehabilitation in these conditions is well 
established amongst service planners and providers. 
Rehabilitation has the potential to reduce the care burden  




both for family (and for society), and associated costs of 
care by improving independence and autonomy. Despite 
availability of health service frameworks (National 
Services Framework, 2005) that promote rehabilitation for 
persons with long term neurological conditions (LTNC) 
such as GBS; and clinical guidelines and standards for 
GBS (Hughes et al., 2005; Asbury and Cornblath, 1990), 
gaining access to appropriate rehabilitation services 
continues to be challenging (Khan and Ng, 2009; 
DeJong, 2005; Khan, 2004; Meythaler, 1997). One 
reason for this is the relatively poor understanding of the 
specific benefits that may derive from rehabilitation in the 
context of this neurological disease. 
Although randomized controlled trials are methodolo-
gically ‘gold standard’ for effectiveness of rehabilitation, 
they cannot answer all the questions that need to be 
answered (Whyte, 2002). Therefore prospective data 
collected systematically in the course of routine clinical 
practice has the potential to provide additional 
information about GBS survivors that will assist in 
understanding the nature of services provided as well as 
the outcomes and service implications. Practice-based 
evidence (Horn et al., 2005) can be used to address 
critical questions such as which patients have the most to 
gain, and what models and intensity of rehabilitation input 
are likely to be most effective (DeJong et al., 2005). 
In Australia, the Australasian rehabilitation outcomes 
centre (AROC) holds a centralised database, which 
gathers a standard set of information on both process 
and outcomes for every person admitted for inpatient (IP) 
rehabilitation. It has data for over 160 accredited 
Australian hospitals (public and private) over the last 7 
years. It provides a national benchmarking service, as 
well as providing information to improve understanding of 
factors that influence rehabilitation outcomes and costs. 
In a previous analysis (Khan et al., 2009), we described 
the broad outcomes from rehabilitation in persons with 
MS. The objective of this study was to examine the 
AROC database for first episode of IP GBS rehabilitation 
to understand the nature, outcomes and service 
implications for GBS survivors in Australia. The primary 
outcomes include improvement in patient functional 
status, hospital length of stay (LOS) and discharge 
destination. In addition the year on year trends in LOS 
and service efficiency were examined, as well as 
comparison of outcomes for service provision between 
the public and private sector. This analysis provides the 
types of information that can be obtained from such a 
dataset, and identifies additional information needed to 
answer the critical questions for rehabilitation in GBS 





AROC dataset and ANSNAP classes 
 
AROC was established in 2002 as a joint initiative of the 





and consumers), although development of the dataset started in 
1999. The dataset comprises case episode data for admissions for 
rehabilitation from participating services across Australia (currently 
> 400,000 episodes of care from 165 rehabilitation units in Australia 
(90 public and 75 private facilities). The AROC dataset includes 42 
items: socio-demographic, medical (impairment codes, co-
morbidities, complications), episode items (admission dates), 
funding and employment details, and outcome data (patient level of 
function at admission and discharge) (Green and Gordon, 2007; 
Eager et al., 1997). The proportion of missing data in the AROC 
dataset items for 2003-08 is available from authors. 
The Australian national subacute and non acute patient 
(ANSNAP) casemix classification system (Eager et al., 1997) was 
designed for sub and non-acute care, recognizing that such 
patients should be classified by treatment goals such as 
improvement in function, rather than by diagnosis and procedure. 
The case episode data is therefore subdivided based on both 
diagnosis and functional level, using the Functional Independence 
Measure (FIM™) (Granger et al., 1990). In 2007 the ANSNAP 
version II (Green and Gordon, 2007) was implemented to reflect the 
clinical and demographic profile of patients that receive IP 
rehabilitation, and included addition of more defined diagnostic 
classes for the neurological impairment groups (such as GBS) to 
ensure consistency in the allocation of patients. Similar to other 
neurological impairments groups the specific ANSNAP II classes for 
GBS are categorized based on functional level using motor score of 
the FIMTM. These include:  
 
- 2-216 (FIM motor (m) scores range 63 - 91)  
- 2-217 (FIM m = 49 - 62)  
- 2-218 (FIM m = 18 - 48), and  
- 2-219 (FIM m = 14 - 17)  
 
AROC holds a territory licence for use of the FIMTM∗ in Australia and 
New Zealand and is the national certification and training centre for 
this tool for all accredited rehabilitation facilities (public and private). 
Clinical staffs are required to complete FIM training, and must sit a 
credentialing exam every 2 years. These procedures maximise the 
quality of data. All data received by AROC are screened for errors 
and missing data, and if necessary the submitting facility is 
requested to review and correct any inconsistencies 
 
 
Data handling and statistical analysis 
 
De-identified data for GBS survivors for first episode of IP 
rehabilitation during the 6 year period between 2003 and 2008 were 
extracted from the main AROC database, cleaned and transferred 
to SPSS version 15 for analysis. Missing and small sample data 
were excluded from the analysis as indicated in Box 1. Descriptive 
analysis included the mean and 95% confidence intervals (CI) for 
demographic, FIM, LOS and discharge destination collated by year, 
ANSNAP class and sector/provider type. Significant differences 
were tested by independent samples t-tests and between subjects 
ANOVA with post hoc pairwise comparisons using Bonferroni 
adjustments for significant ANOVA results. Given the large sample 
size, effect sizes (Cohen’s d) were calculated for each t-test to 





A total of 577 first episodes for GBS inpatient 
rehabilitation were submitted to  AROC  during  the  study  
                                                 
∗ FIM™ is a trademark of the Uniform Data System for Medical Rehabilitation, 
a division of UB Foundation Activities, Inc. 




Table 1. Demographics split by ANSNAP class for GBS survivors for 2003-2008. 
 
 216 217 218 219 Total P- value 
Number of episodes 203 125 226 23 577  









   
Private 27.6 35.2 18.6 4.3 24.8 0.001 
Public 72. 64.8 81.4 95.7 75.2  
 
Gender (%) 
      
Female 47.3 42.4 37.3 39.1 42.0 0.340 
Male 52.7 57.6 62.7 60.9 58.0  
 















108.2 (107.1-109.4) 88.7(87.7-89.7) 66.1 (64.7-67.6) 48.8 (46.3-51.2) 85.9 (84.1-87.6) 0.000 
Discharge FIM 
(mean+95%CI 













      
Discharged to community 97.0% 92.0 86.3 73.9 90.9 0.000 
Remaining in hospital 
system 
3.0% 8.0 13.7 26.1 9.1  
FIM improvement 
(mean+95%CI) 
10.9 (9.9-12.0) 23.0 (21.0-25.1) 33.0 (30.1-35.8) 37.7 (22.6-52.8) 22.9 (21.3-24.5) 0.000 
FIM efficiency (FIM 
gain/LOS) 
0.68 0.89 0.87 0.62 0.81  
 
GBS, Guillain Barre syndrome; ANSNAP, Australian national subacute and non acute patient casemix classification system; CI, confidence interval; FIM, functional 




period (2003 - 2008) and included in the analysis below. 
 
 
Differences between ANSNAP classes 
 
Patient demographics split by ANSNAP class are 
provided in Table 1. Approximately 91% (n = 518) were 
discharged into the community, with only 9% (n = 52) 
remaining in the hospital system. The majority of 
admissions 554 (96%) were in the highest functioning 
three classes (ANSNAP 216,217 and 218), with only 23 
(n = 4%) in the very disabled class (ANSNAP 219). 
However, some interesting patterns emerge: 
 
- Gender: There were more male patients in all ANSNAP 
classes with more males (>60%) in the lowest functioning 
classes 218 and 219.  
- Public versus private sector: Whilst in each ANSNAP 
class the majority of cases were treated in the public 
sector, this trend becomes more pronounced in the 
lowest functioning two classes (218 and 219). 
- LOS   increases    progressively   with   loss  of  function 
across the 4 classes with a four fold difference between 
classes 216 (mean 16.2 days) and 219 (mean 60.5 days) 
(p 0.000).  
 
The ANSNAP classes 216 - 19 all showed significant 
improvements in FIM scores from admission to discharge 
(Table 1). FIM improvement differed between the four 
ANSNAP classes, 219 had the most FIM change 
compared to class 216 (mean FIM change 37 versus 10) 
(p 0.000). This is expected as the lower the admission 
FIM scores the greater is the potential for possible 
improvement. Those with greater functional impairments 
were less able to return to their usual accommodation in 
the community. FIM efficiency was also higher in the 
middle classes 217 and 218 than in classes 216 and 219, 
likely due to the floor and ceiling effect of FIM. 
The number of cases reported per year increased from 
60 in 2003 and 123 in 2008. This is in line with the growth 
of facilities reporting to AROC over that period. The ratio 
of episodes per facility did not change substantially 
between 2003 and 2008. Table 2 shows there were no 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3. Comparison of outcomes for GBS survivors in public and private facilities. 
  
 Public Private Mean difference +95%CO P value Effect size 
# episodes 434 143    
Age (years; mean+95%CI) 55.8 (54.1-57.5) 59.6 (56.8-62.4) 3.8 (0.4-7.2) 0.027 -0.21 
Admission FIM (mean+95%CI) 84.4 (82.3-86.5) 90.2 (87.1-93.3) 5.8 (1.8-9.9) 0.005 -0.27 
Discharge FIM (mean+95%CI) 108.2 (106.2-110.2) 110.4 (107.5-113.4) 2.2 (-1.6-6.0) 0.257 -0.11 
LOS (Mean+95%CI) 29.6 (27.5-31.7) 23.7 (20.7-26.6) -6.0 (10.0-2.0) 0.004 0.28 
 
Discharge destination (%) 
     
Discharged to community 89.9 93.7  0.175  
Remaining in hospital system 10.1 6.3    
FIM improvement (mean+95%CI) 23.8 (22.0-25.7) 20.2 (17.4-23.0) -3.6 (-7.2-0.0) 0.048  
FIM efficiency (FIM gain/LOS) 0.80 0.85    
 




Table 4. Comparison of hospital length of stay and FIM change across ANSNAP classes for GBS survivors in public 
and private facilities  
 
 ANSNAP class Public Private 




































































ANSNAP Australian National subacute and Non acute patient casemix classification system; CI Confidence Interval; FIM 




‘nadir’ which can peak over a 3 - 6 week period after 
contracting the illness, and may somewhat blur the 
ANSNAP class allocation in the initial stages. More 
detailed description of the FIM motor scores for all 
ANSNAP classes is beyond the scope of this study and 
will be presented in a separate report. 
As reported previously (Khan et al., 2009), the 
originators of FIM (uniform data systems) use FIM 
efficiency as a marker  for  cost  efficiency, benchmarking 
and outcomes of rehabilitation research. The floor and 
ceiling effects of the FIM scale, its ordinal nature, and 
separate motor and cognitive domains scores do not lend 
themselves to total summation scores nor manipulation 
such as division by LOS to derive measures for 
efficiency. Other studies (Turner et al., 2006) show that 
FIM efficiency does not indicate cost efficiency outside 
the middle range for more dependant patients. Further 
information is  needed  to see if differences reported here  




are clinically meaningful for GBS survivors. Other factors 
impacting outcomes such as the cost implications of GBS 
care are beyond the scope of this study. 
The usefulness of the AROC dataset depends on 
trained accredited staff and submission of accurate data, 
which is resource intensive. The year on year data shows 
reduction in missing data but other data fields have 
information that is hard to interpret clinically (such as time 
of onset, disease ‘nadir’). Information about patient 
functional dependency is available, however other 
information not currently collected includes:  
 
- Duration of ventilation, length of stay in intensive care 
setting. 
- Type of treatment (plasmaphoresis, intravenous 
gammaglobulin and others).  
- Range and severity of neurological impairments. 
- Type of treatment provided that is ’black box’ 
(disciplines involved, intensity of treatment, key 
intervention).  
- Outcomes relating to participation and community 
reintegration (note - the AROC ambulatory dataset has 
commenced data collection in 2009). 
 
All of the above indicate complexity of need for 
rehabilitation and expected outcomes. In addition to the 
AROC dataset, additional disease specific (GBS) 
datasets can be recorded alongside for a more 
informative comparison. 
The World Health Organization’s, International Classifi-
cation of Functioning and Health (ICF) (WHO, 2001), 
provides a framework and common language to describe 
impact of GBS for limitation in activity and participation. 
Recently we listed patient reported disability following 
GBS and linked these with the ICF categories to highlight 
domains considered important by persons with GBS in 
multidisciplinary care settings (Khan et al., 2009, 
submitted for publication). In addition we have developed 
a preliminary Australian ‘core’ set of ICF categories for 
GBS survivors (Khan and Pallant, 2009, submitted for 
publication), using a delphi consensus exercise to 
facilitate communication and multidisciplinary assess-
ments in subacute settings. In the future these may be 
used to supplement AROC information for defined 
rehabilitation outcomes in this population. 
Compared with stroke and parkinson disease 
population (AROC, University of Woollongong NSW, 
Australia, personal communication), most GBS survivors 
are young and expected to make a good recovery 
(Bernson et al., 2002; Meythaler, 1997). However the 
longer term neurological sequale of GBS and outcomes 
are not clear. The AROC dataset is a unique resource 
and a valuable research tool for describing rehabilitation 
outcomes in ‘real life settings’. However more specific 
GBS information needs to be collected alongside the core 
AROC data for more meaningful evaluation of outcomes 
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